PPI test in GP patients
Study identifier:25N54
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
The proton pump inhibitor test in reflux disease: a study using Nexium in general practice patients
Medical condition
GERD
Phase
Phase 4
Healthy volunteers
No
Study drug
Esomeprazole
Sex
All
Actual Enrollment
100
Study type
Interventional
Age
18 Years +
Date
Study Start Date: 01 Jan 2003
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: Non-randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
Utrecht University Medical Center
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
AstraZeneca Netherlands Medical Director
AstraZeneca
